Success Metrics

Clinical Success Rate

97.3%

Based on 108 completed trials

Completion Rate

97%(108/111)

Active Trials

70(26%)

Results Posted

25%(27 trials)

Terminated

3(1%)

Phase Distribution

Ph phase_3

Ph early_phase_1

Ph not_applicable

230

87%

Ph phase_1

Ph phase_4

Ph phase_2

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution264 total trials

Early Phase 1First-in-human

1(0.4%)

Phase 1Safety & dosage

10(3.8%)

Phase 2Efficacy & side effects

15(5.7%)

Phase 3Large-scale testing

4(1.5%)

Phase 4Post-market surveillance

4(1.5%)

N/ANon-phased studies

230(87.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.0%

108 of 120 finished

Non-Completion Rate

10.0%

12 ended early

Currently Active

trials recruiting

Total Trials

265

all time

Status Distribution

Active(104)

Completed(108)

Terminated(12)

Other(41)

Detailed Status

Completed108

Recruiting66

unknown40

Not yet recruiting30

Withdrawn9

Enrolling by invitation4

Development Timeline

Analytics

Development Status

Total Trials

265

Active

Success Rate

97.3%

Most Advanced

Phase 4

Trials by Phase

Early Phase 11 (0.4%)

Phase 110 (3.8%)

Phase 215 (5.7%)

Phase 34 (1.5%)

Phase 44 (1.5%)

N/A230 (87.1%)

Trials by Status

enrolling_by_invitation42%

active_not_recruiting42%

recruiting6625%

suspended10%

terminated31%

unknown4015%

withdrawn93%

completed10841%

not_yet_recruiting3011%

Recent Activity

70 active trials

Showing 5 of 265

recruitingphase_1

Temporal Interference for Thalamocortical Activity and Network Modulation

NCT07219719

completednot_applicable

Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine

NCT06003036

recruitingnot_applicable

Clinical Trials (265)

Showing 20 of 265 trialsScroll for more

NCT07219719Phase 1

Temporal Interference for Thalamocortical Activity and Network Modulation

Recruiting

NCT06003036Not Applicable

Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine

Completed

NCT05794295Not Applicable

Sleep Architecture & Cognition in Focal Epilepsy

Recruiting

NCT03029884Not Applicable

Closed-loop Deep Brain Stimulation to Treat Refractory Neuropathic Pain

Completed

NCT06434766Not Applicable

Multicenter iTBS Neuromodulation for PTSD Treatment

Recruiting

NCT05043051Not Applicable

Autoimmune Basis for Postural Tachycardia Syndrome

Completed

NCT07553364Not Applicable

Auditory Stimulation for Insomnia and Depression

Not Yet Recruiting

NCT07520955Not Applicable

Lily's Grace Temporal Interference

Not Yet Recruiting

NCT06323954Not Applicable

tVNS During Motor Training in Older Adults

Recruiting

NCT07442058Not Applicable

Accelerated and Extended-iTBS Targeting Inhibitory Control in Veterans With ADHD

Not Yet Recruiting

NCT04437498Not Applicable

Vagal Nerve Stimulation in mTBI

Recruiting

NCT07647380Not Applicable

TIS for Improving Cognitive Impairment in Schizophrenia

Recruiting

NCT07701343Not Applicable

tACS for Working Memory in Schizophrenia

Recruiting

NCT07699783Phase 1

Transcranial Ultrasound Stimulation for Tourette Syndrome

Not Yet Recruiting

NCT07689981Not Applicable

The Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation in Individuals With Tiletamine Use Disorder

Not Yet Recruiting

NCT07686302Not Applicable

Feasibility of Noninvasive Trigeminal Nerve Stimulation During Exercise

Not Yet Recruiting

NCT07680153Phase 4

Neuromodulation of Mood Switch Circuitry in Bipolar Disorder

Not Yet Recruiting

NCT07668167Not Applicable

Combined Regulatory Effects of 40 Hz eTNS and Multisensory Stimulation on Brain Networks

Recruiting

NCT05269953Not Applicable

Median Nerve Stimulation for Tourette Syndrome and Chronic Tic Disorder

Completed

NCT07660250Not Applicable

Vagus Nerve Stimulation for Myelopathy

Recruiting

Drug Details

Intervention Type: DEVICE
Total Trials: 265